Drug Profile
HIV vaccine - GSK
Alternative Names: 732461; 732462; GSK-732462; GSK732461; SB-732461; SB-732462Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 30 Jan 2018 GlaxoSmithKline completes a phase I trial in HIV infections in Belgium (IM) (NCT03368053)
- 14 Dec 2017 GlaxoSmithKline initiates enrolment in a phase I trial in HIV infections in Belgium (IM) (NCT03368053)
- 01 May 2014 GlaxoSmithKline completes a phase I follow-up trial in IV infections in Germany, France, Spain and USA (NCT01092611)